ATI RN
NCLEX questions on chemotherapy drugs Questions
Question 1 of 5
Which is NOT an advantage of dalteparin over unfractionated heparin?
Correct Answer: D
Rationale: Dalteparin (a low-molecular-weight heparin) has greater bioavailability, less thrombocytopenia risk, and a longer half-life than unfractionated heparin, but greater efficacy is not a consistent advantage, as it depends on the condition treated.
Question 2 of 5
The following is NOT an advantage of rivaroxiban and dabigatran over warfarin:
Correct Answer: C
Rationale: Rivaroxaban and dabigatran have rapid onset/offset, no INR monitoring, and fewer CYP450 interactions, but both require dose adjustments in renal failure due to renal clearance, unlike warfarin.
Question 3 of 5
Concerning argatroban (direct thrombin inhibitor), the following is Wrong:
Correct Answer: C
Rationale: Argatroban is IV, used in HIT, and not reversed by protamine, but it’s monitored by aPTT, not INR (which is for warfarin).
Question 4 of 5
Reduction in calcium absorption from GIT is associated with the use of:
Correct Answer: D
Rationale: Alendronate (bisphosphonate) and prednisone (glucocorticoid) reduce GI calcium absorption; raloxifene doesn’t, and alfacalcidiol (vitamin D) enhances it.
Question 5 of 5
The following is (are) used in acromegaly and in Parkinsonism:
Correct Answer: D
Rationale: Bromocriptine (D2 agonist) treats acromegaly (reduces GH) and Parkinsonism (mimics dopamine). L-dopa also treats Parkinsonism. Octreotide is for acromegaly only.